Trial intelligence / Profile preview

Nebulized Tobramycin for Bronchiectasis Acute Exacerbation

NCT01677403Phase 4Unknown

Sponsor
Shandong University
Start
Aug 2012
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tobramycin in bronchiectasis, sponsored by Shandong University. Status: unknown.

02

Drugs

tobramycin
03

Conditions

bronchiectasis

Beyond the preview

Go deeper on NCT01677403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01677403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call